September 27, 2020

The Niche

Knoepfler lab stem cell blog

Athersys (ATHX)

2 min read

I try to catch up on my science reading over the weekends and evenings. Here’s my recommended weekend reading on stem cells & science. Did I miss anything especially cool? Let me know in the comments. Direct reprogramming of skin cells into insulin-producing cells. I love direct reprogramming. Healios and Athersys Enter Into Regenerative Medicine Partnership. Can they together create regen med success? National honor for helping “the blind see” comes from CIRM blog. Fun piece on CRISPR language by Ben Zimmer. ‘Crispr’ Breaks Out Of the Lab. …Read More

2 min read

To get from point A of a stem cell discovery to point B of a patient actually receiving a treatment based on that discovery is a long and non-linear road, which requires biotech company research. Stem cell biotech companies including publicly traded companies are an integral part of the field making that journey. How those companies fare financially is not just of interest to investors, but also should be on the radar screen of scientists and advocates too. Lately, stem cell companies have not …Read More